Table 2.
Pre Stroke Baseline characteristics of OXVASC patients n (%) unless stated otherwise plus antiplatelet, antihypertensive and statin treatments at one month. CE = Cardio embolic, LAA = Large artery, SMV = small vessel, UND = undefined, UNK = unknown. PVD = peripheral vascular disease, MI = myocardial infarction.* n = 1159 all patients, n = 416 TIA, n = 743 stroke, *†n=1124, n=396 TIA, n=728 stroke.
| Baseline Characteristics | All patients n = 1292 | TIA n = 435 | Stroke n = 857 |
|---|---|---|---|
| Age years mean(SD) | 73.07(13.25) | 71.97(13.16) | 73.07(13.25) |
| Male sex | 617 (48) | 201 (46) | 416 (49) |
| TOAST* | |||
| CE | 258 (22) | 69 (17) | 189 (25) |
| LAA | 143 (12) | 50 (12) | 93 (13) |
| SMV | 191 (17) | 40 (10) | 153 (21) |
| UND | 482 (42) | 231 (56) | 251 (34) |
| UNK | 82 (7) | 26 (6) | 56 (8) |
| Incident Event | 1059 (82) | 332 (76) | 727 (85) |
| Previous Stroke | 170 (13) | 45 (10) | 125 (15) |
| Previous TIA | 176 (14) | 74 (17) | 102 (12) |
| Atrial Fibrillation | 227 (18) | 65 (15) | 162 (19) |
| Antiplatelet *† | 457 (41) | 148 (37) | 309 (42) |
| At one month | 1176 (91) | 418 (96) | 754 (88) |
| Antihypertensive*† | 652 (59) | 215 (55) | 437 (60) |
| At one month | 965 (75) | 313 (72) | 654 (76) |
| Statin n/total *† | 256 (23) | 103 (26) | 153 (21) |
| At one month | 949 (74) | 320 (74) | 629 (73) |
| PVD | 103 (8) | 30 (7) | 73 (9) |
| Smoker | 207 (16) | 60 (14) | 147 (17) |
| Previous MI | 128 (10) | 42 (10) | 86 (10) |
| Hypertension | 767 (59) | 221 (51) | 546 (64) |
| Diabetes | 155 (12) | 55 (13) | 100 (12) |
| Hyperlipid | 413 (32) | 143 (33) | 270 (32) |
| Previous angina | 212 (16) | 68 (16) | 144 (17) |